Gabapentin

CAT: 0804-HY-A0057-01Size: 10 mgDry Ice: NoHazardous: No
HY-A0057-0110 mg
Selected
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Gabapentin is a potent, orally active P/Q type Ca2+ channel blocker. Gabapentin inhibits neuronal Ca2+ influx and reduction of neurotransmitter release. Gabapentin is a GABA analog that can be used to relieve neuropathic pain[1][2][3].
CAS Number
[60142-96-3]
UNSPSC
12352211
Hazard Statement
H315, H319, H335, H360
Target
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/Gabapentin.html
Purity
99.49
Solubility
DMSO : 1 mg/mL (ultrasonic) |H2O : 50 mg/mL (ultrasonic)
Smiles
O=C(O)CC1(CN)CCCCC1
Molecular Formula
C9H17NO2
Molecular Weight
171.24
Precautions
H315, H319, H335, H360
References & Citations
[1]Fink K, et, al. Inhibition of neuronal Ca (2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol. 2000 Jun;130 (4) :900-6.|[2]Celikyurt IK, et, al. Gabapentin, A GABA analogue, enhances cognitive performance in mice. Neurosci Lett. 2011 Apr 1;492 (2) :124-8.|[3]Meymandi MS, et, al. Gabapentin action and interaction on the antinociceptive effect of morphine on visceral pain in mice. Eur J Anaesthesiol. 2008 Feb;25 (2) :129-34.
Shipping Conditions
Room Temperature
Storage Conditions
Store at room temperature 3 years
Scientific Category
Reference compound1
Clinical Information
Launched
Citation 01
ACS Pharmacol Transl Sci. 2023 Mar 6;6 (4) :519-525.|Br J Pharmacol. 2025 Aug 9.|Cell Rep. 2019 Dec 17;29 (12) :3847-3858.e5.|iScience. 2023 Jul 3;26 (8) :107264.|J Nat Med. 2022 Jan;76 (1) :268-275.|J Pain. 2019 May;20 (5) :577-591. |Mol Biol Rep. 2025 Sep 3;52 (1) :859.|Neuropharmacology. 2024 Dec 21:110276.|Pharmacol Res Perspect. 2021 Oct;9 (5) :e00879.|Sci Total Environ. 2022 Jul 10;829:154437.|Eur J Drug Metab Pharmacokinet. 2022 Sep;47 (5) :639-652.

Related Products

CatalogName